Sweden
· Delayed Price · Currency is SEK SynAct Pharma AB Statistics
Total Valuation
STO:SYNACT has a market cap or net worth of SEK 824.33 million. The enterprise value is 774.81 million.
| Market Cap | 824.33M |
| Enterprise Value | 774.81M |
Important Dates
The last earnings date was Tuesday, May 27, 2025.
| Earnings Date | May 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:SYNACT has 49.01 million shares outstanding. The number of shares has increased by 27.68% in one year.
| Current Share Class | 49.01M |
| Shares Outstanding | 49.01M |
| Shares Change (YoY) | +27.68% |
| Shares Change (QoQ) | +16.45% |
| Owned by Insiders (%) | 18.08% |
| Owned by Institutions (%) | 18.73% |
| Float | 23.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 4.55 |
| P/TBV Ratio | 4.55 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -9.43 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.46, with a Debt / Equity ratio of 0.01.
| Current Ratio | 6.46 |
| Quick Ratio | 5.91 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -34.03 |
Financial Efficiency
Return on equity (ROE) is -49.29% and return on invested capital (ROIC) is -34.29%.
| Return on Equity (ROE) | -49.29% |
| Return on Assets (ROA) | -26.61% |
| Return on Invested Capital (ROIC) | -34.29% |
| Return on Capital Employed (ROCE) | -44.28% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -13.70M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -12.92M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +138.24% in the last 52 weeks. The beta is 0.99, so STO:SYNACT's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +138.24% |
| 50-Day Moving Average | 18.27 |
| 200-Day Moving Average | 13.11 |
| Relative Strength Index (RSI) | 46.26 |
| Average Volume (20 Days) | 314,774 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -92.06M |
| Pretax Income | -95.10M |
| Net Income | -82.18M |
| EBITDA | n/a |
| EBIT | -92.06M |
| Earnings Per Share (EPS) | -1.92 |
Balance Sheet
The company has 51.16 million in cash and 1.64 million in debt, giving a net cash position of 49.52 million or 1.01 per share.
| Cash & Cash Equivalents | 51.16M |
| Total Debt | 1.64M |
| Net Cash | 49.52M |
| Net Cash Per Share | 1.01 |
| Equity (Book Value) | 181.14M |
| Book Value Per Share | 3.70 |
| Working Capital | 61.54M |
Cash Flow
| Operating Cash Flow | -106.83M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:SYNACT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.68% |
| Shareholder Yield | n/a |
| Earnings Yield | -9.97% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |